Overview This page contains the latest trade data of Heterocyclic compounds with unfused imidazole ring,ne. In 2023, Heterocyclic compounds with unfused imidazole ring,ne were the world's 1544th most traded product, with a total trade of $1.76B. Between 2022 and 2023 the exports of Heterocyclic compounds with unfused imidazole ring,ne decreased by -22.3%, from $2.26B to $1.76B. Trade in Heterocyclic compounds with unfused imidazole ring,ne represent 0.0078% of total world trade.
Heterocyclic compounds with unfused imidazole ring,ne are a part of Nitrogen Heterocyclic Compounds.
Exports In 2023 the top exporters of Heterocyclic compounds with unfused imidazole ring,ne were China ($434M), India ($217M), France ($203M), Germany ($146M), and United States ($115M).
Imports In 2023 the top importers of Heterocyclic compounds with unfused imidazole ring,ne were United Kingdom ($196M), United States ($120M), France ($115M), Japan ($115M), and China ($98.1M).
Ranking Heterocyclic compounds with unfused imidazole ring,ne ranks 165th in the Product Complexity Index (PCI).
Description Imidazole is part of the purine family of heterocyclic compounds. It is found in many natural products, such as histidine and adenosine. Imidazole-based drugs can treat a variety of conditions, including peptic ulcers, Parkinson's disease, and thrombocytopenia.